| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 64.787 | 73.228 | 77.590 | 59.028 | 49.101 | 44.625 | 76.175 | 74.550 | 78.052 | 87.286 |
| Total Income - EUR | 74.850 | 79.910 | 82.221 | 61.205 | 60.120 | 46.223 | 76.188 | 79.702 | 87.667 | 89.133 |
| Total Expenses - EUR | 87.057 | 72.334 | 61.570 | 61.322 | 67.087 | 38.548 | 52.652 | 38.675 | 56.301 | 58.925 |
| Gross Profit/Loss - EUR | -12.207 | 7.576 | 20.652 | -117 | -6.967 | 7.675 | 23.536 | 41.027 | 31.366 | 30.207 |
| Net Profit/Loss - EUR | -12.207 | 5.574 | 18.108 | -1.954 | -8.771 | 6.384 | 21.250 | 38.849 | 29.849 | 25.795 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Derma Line Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 142.499 | 126.767 | 89.927 | 54.295 | 59.562 | 42.688 | 28.340 | 20.991 | 11.869 | 108.475 |
| Current Assets | 17.822 | 22.286 | 40.945 | 20.391 | 31.414 | 39.979 | 73.260 | 26.792 | 65.184 | 37.077 |
| Inventories | 6.338 | 4.796 | 5.526 | 7.392 | 5.189 | 4.353 | 3.381 | 2.092 | 14.015 | 6.485 |
| Receivables | 4.943 | 8.983 | 2.074 | 2.334 | 5.569 | 5.739 | 9.203 | 6.552 | 17.119 | 12.188 |
| Cash | 6.541 | 8.507 | 33.346 | 10.665 | 20.656 | 29.888 | 60.677 | 18.149 | 34.051 | 18.404 |
| Shareholders Funds | -41.304 | -35.309 | -16.604 | -18.253 | -26.670 | -19.780 | 1.908 | 38.897 | 29.896 | 25.842 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 201.625 | 184.362 | 147.476 | 92.939 | 117.646 | 102.448 | 99.692 | 8.885 | 47.157 | 119.710 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4775 - 4775" | |||||||||
| CAEN Financial Year |
4775
|
|||||||||
Comments - Derma Line Srl